OTC - ACTIVE INGREDIENT SECTION
SALICYLIC ACID 1%
SALICYLIC ACID 1%
MILAREMOVER
Smooth Skin Concentrate MILIA CLEARING SKIN ESSENCE
FOR EXTERNAL USE ONLY.
DO NOT USE IF PREGNANT, NURSING,OR TRYING TO CONCEIVE.
AVOID CONTACT WITH EYES.IF CONTACT OCCURS, RINSE THOROUGHLY WITH WATER.
IFIRRITATION OR RASH DEVELOPS, DISCONTINUE USE AND CONSULT AHEALTHCAREPROVIDER.
KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP ORCONTACTAPOISON CONTROL CENTER IMMEDIATELY.
1.APPLY DAILY AFTER CLEANSING AND TONING. USE TWICEADAY FORAT LEAST 4 WEEKS.
2.DISPENSE APEA-SIZE AMOUNT OF THE ESSENCE ONTYOUR FINGERTIPS UNTILFULLYABSORBED.DNGER VISIBLE.
3.CONTINUE USE CONSISTENTLY UNTIL MILIAARE NO LC
O THE PROBLEMATIC AREA, AND GENTLY MASSAGE WITH
BUTYLENE GLYCOL
SQUALANE
DIMETHICONE, UNSPECIFIED
CAFFEINE
PANTHENOL
4-HYDROXYBENZALDEHYDE
1,2-HEXANEDIOL
GLYCYRRHIZINATE DIPOTASSIUM
CARBOMER
ARGININE
HYALURONATE SODIUM
TRANSCROCETIN
Dextrin
HYDROXYPHENYL PROPAMIDOBENZOIC ACID
WATER
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 87278-005-01 | Milia remover | 15 mL in 1 BOTTLE | CREAM | 15 | 1 | |
| 87278-005-02 | Milia remover | 30 mL in 1 BOTTLE | CREAM | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 87278-005 | 87278-005-01, 87278-005-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Milia remover | SALICYLIC ACID | Guangxi Keyun E-commerce Co., Ltd. | 4d6fd754-bfa0-d810-e063-6394a90a8742 | 2026-03-20 | Warnings | 87278-005-01 87278-005-02 87278-005 87278000502 87278000501 4d6fd754-bfa1-d810-e063-6394a90a8742 4d6fd754-bfa0-d810-e063-6394a90a8742 |
Adverse event summaries are temporarily unavailable. Other product information remains available.